In prostate cancer, KLF6 is considered a tissue-specific structure-specific prognostic marker for prostate cancer [47]; inactivation or overexpression of KLF6 as a tumor suppressor produces a protumorigenic effect and facilitates tumor progression [46,48,49]. The gene discussed is KLF6; the disease is prostate carcinoma.